Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Workday Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Workday Inc trades at $189.77 (market cap $44.83B). The key difference: Workday Inc is far larger — about 5.1× Kymera Therapeutics Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Workday Inc for 38 Days on average.
| KYMR | WDAY | |
|---|---|---|
Market Cap | $8.87B | $44.83B |
Volume | 779,107 | 2,168,736 |
Sector | Health | Technology |
52-Week High | $127.31 | $245.67 |
52-Week Low | $55.80 | $112.55 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $8.26B | $45.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Workday (WDAY) trades at $186.02, down 1.18% on the day, reflecting a recent market pullback amid broader tech sector volatility. The stock maintains a bullish technical signal with strong analyst consensus support, evidenced by 50.6% buy ratings and a $203.19 average price target. Recent earnings beats and a 200% YoY surge in AI Annual Recurring Revenue to $600 million highlight robust fundamental momentum, though net cash flow turned negative in 2025 due to strategic investments.
WDAY's outlook remains positive, driven by AI integration and expansion into new markets like the UAE, but risks include execution challenges from recent layoffs and heightened competition. The stock's premium valuation (P/E 37.89) requires sustained high growth to justify further upside, making earnings performance the critical near-term catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
